|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Common variation in the LMNA gene (encoding lamin A/C) and type 2 diabetes - Association analyses in 9,518 subjects显示文摘 | Owen, KR Groves, CJ Hanson, RL Knowler, WC Shuldiner, AR Elbein, SC Mitchell, BD Froguel,P Ng, MCY Chan, JC Jia, WP Deloukas, P Hitman, GA Walker, M Frayling, TM Hattersley, AT Zeggini, E McCarthy, MI | 2007 | 中国生物学文摘2007，21，11： | 2 |
| 2 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of elopidogrel therapy 显示文摘 | Shuldiner AR O'Connell JR Bliden KP | 2009 | JAM A2009，302，8： | 1 |
| 3 | Resistin,obesity and in-sulin resistance the emerging role of the adipocyte as an endocrine organ显示文摘 | Shuldiner AR Yang R Gong DW | 2001 | N Engl J Med2001，345，18： | 1 |
| 4 | The relation betweenCYP2C19 genotype and phenotype in stented patients on mainte-nance dual antiplatelet therapy 显示文摘 | Gurbel PA Shuldiner AR Bliden KP | 2011 | Am Heart /2011，161，： | 1 |
| 5 | Obesitygene variant and elite endurance performance显示文摘 | Moore Geoffrey E Shuldiner Alan R Zmuda J0seph M Ferrell Robert E Mccole Steve D Hagberg James M | 2001 | Metabolism Clinical and Experimental2001，50，12： | 1 |
| 6 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy显示文摘 | Shuldiner A R O'Connell J R Bliden K P | 2009 | JAMA2009，302，8： | 1 |
| 7 | The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity显示文摘 | CELl F S SHULDINER A R | 2002 | Curr Diab Rep2002，2，2： | 1 |
| 8 | Association of tyro-chrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of elopidogrel therapy显示文摘 | Shuldiner AR OConnell JR Bliden KP | 2009 | JAMA2009，302，8： | 1 |
| 9 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy显示文摘 | Shuldiner AR O'Connell JR Bliden KP | | 0，，： | 1 |
| 10 | Association of cytoehrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy显示文摘 | Shuldiner A R O'Connell J R Bliden K P | 2009 | JAMA2009，302，8： | 1 |
| 11 | Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects 显示文摘 | WEISS E P BROWN M D SHULDINER A R | 2002 | Physiol Ge- nomics2002，10，3： | 1 |
| 12 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy显示文摘 | Shuldiner AR O'Connell JR Bliden KP | | 0，，08： | 1 |
| 13 | Interactions between variants in the beta3 - adrenergic receptor and peroxisome proliferators - activated receptor- gamma2 genes and obesity显示文摘 | Hsueh WC Cole SA Shuldiner AR Beamer BA Blangero J Hixson JE MacCluer JW Mitchell BD | 2001 | Diabetes Care2001，24，4： | 1 |
| 14 | The insulin-like growth factor 1 (IGF-1) gene is expressed in chickembryos during early organogenesis 显示文摘 | Serrano J Shuldiner A R Roberts C T | 1990 | Endocrinology1990，127，3： | 1 |
| 15 | Ass-cioation of cytochrome P450 2C19 genotype with the antiplateleteffect and clinical efficacy of clopidogrel therapy 显示文摘 | SHULDINER A R (TCONNELL J R BLIDEN K P | 2009 | JAMA2009，302，8： | 1 |
| 16 | Association of a polymorphism in the beta 3 - adrenergic - receptor gene with features of the insulin resistance syndrome in Finns显示文摘 | Widen E Lehto M Kanninen T Walston J Shuldiner AR and Groop LC | 1995 | N Eng J Med1995，333，6： | 1 |
| 17 | Genetics of obesity: more complicated than initially thought 显示文摘 | Shuldiner AR Munir KM | 2003 | Lipids2003，38，2： | 1 |
| 18 | Genotyping: one piece of the puzzle to personalize antiplatelet therapy显示文摘 | Gurbel P A Tantry U S Shuldiner A R etal | 2010 | J Am Coil Cardiol2010，56，2： | 1 |
| 19 | Interactions between variants in the beta3-adrenergic receptor and peroxisome proliferators-activated receptor-gamma2 genes and obesity显示文摘 | HSUEH W C COLE S A SHULDINER A R | 2001 | Diabetes Care2001，24，4： | 1 |
| 20 | Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy 显示文摘 | Shuldiner AR O' Connell JR Bliden KP | 2009 | JAMA2009，302，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员